Filtros: Autor es Moreno, V [Restablecer todos los filtros]
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(10):1216-22.
Integrative analysis of a cancer somatic mutome. Molecular cancer. 2007;6:13.
Tumour selection advantage of non-dominant negative P53 mutations in homozygotic MDM2-SNP309 colorectal cancer cells. Journal of medical genetics. 2007;44(1):75-80.
Genetic variation in 8q24 associated with risk of colorectal cancer. Cancer biology & therapy. 2007;6(7):1143-7.
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis. 2007;28(6):1241-6.
Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. European journal of cancer (Oxford, England : 1990). 2007;43(4):762-8.
SNPassoc: an R package to perform whole genome association studies. Bioinformatics (Oxford, England). 2007;23(5):644-5.
Genomic and transcriptomic prognostic factors in R0 Dukes B and C colorectal cancer patients. International journal of oncology. 2007;30(5):1099-107.
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
WAERS: an application for Web-assisted estimation of relative survival. Medical informatics and the Internet in medicine. 2007;32(3):169-75.
Maximizing association statistics over genetic models. Genetic epidemiology. 2008;32(3):246-54.
The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe. Journal of hepatology. 2008;49(2):233-42.
Primary cardiac osteosarcoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2008;10(8):515-6.
Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes. BMC medical genomics. 2008;1:62.
CLEAR-test: combining inference for differential expression and variability in microarray data analysis. Journal of biomedical informatics. 2008;41(1):33-45.
Caspase-3 activity, response to chemotherapy and clinical outcome in patients with colon cancer. International journal of colorectal disease. 2008;23(1):21-7.
Functional characterization of the novel APC N1026S variant associated with attenuated familial adenomatous polyposis. Gastroenterology. 2008;134(1):56-64.
Genetic and genomic analysis modeling of germline c-MYC overexpression and cancer susceptibility. BMC genomics. 2008;9:12.
Accounting for error due to misclassification of exposures in case-control studies of gene-environment interaction. Statistics in medicine. 2008;27(15):2756-83.
Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2008;105(11):4306-11.
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nature genetics. 2008;40(5):631-7.
Tests for gene-environment interaction from case-control data: a novel study of type I error, power and designs. Genetic epidemiology. 2008;32(7):615-26.
Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(30):4966-72.